Aim: To evaluate the zero-citation sizes.
Material And Methods: Based on the data of the Russian Science Citation Index the publication activity of four leading institutes in the field of Psychiatry and Addiction is analyzed. The same indices in the field of Neurology were used as a control. Number and percentage of publications with ≥1 citations and zero-citation were analyzed.
Results: It has been shown that in psychiatric science zero citation rate is quite high (from 32.8% to 47.2%, an average of 42.9%). It is higher compared to the control.
Conclusion: Zero-citation indicator is essential to evaluate the effectiveness of scientific institutions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/jnevro201711710192-100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bias in machine learning applications to address non-communicable diseases at a population-level: a scoping review.
BMC Public Health
December 2024
Upstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, Unity Health Toronto, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Background: Machine learning (ML) is increasingly used in population and public health to support epidemiological studies, surveillance, and evaluation. Our objective was to conduct a scoping review to identify studies that use ML in population health, with a focus on its use in non-communicable diseases (NCDs). We also examine potential algorithmic biases in model design, training, and implementation, as well as efforts to mitigate these biases.
View Article and Find Full Text PDFIn Reply to the Letter to the Editor Regarding: "Self-Citation Rates Among Neurosurgery Journals and Authors: Unethical or Misunderstood?".
World Neurosurg
December 2024
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. Electronic address:
Wearable devices, ischemic heart disease and cardiovascular outcomes: A systematic review and meta-analysis.
Maturitas
December 2024
Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom. Electronic address:
Objectives: To evaluate the impact of wearable devices when associated with usual care on the incidence of major adverse cardiovascular events (MACE) in patients with ischemic heart disease compared with usual care alone.
Methods: Randomised clinical trials with patients aged 18 years and above with ischemic heart disease, using wearable devices and assessing at least one of the primary outcomes (myocardial infarction, stroke, cardiovascular mortality, or major adverse cardiovascular events) or secondary outcomes (all-cause mortality, hospitalisation, all arrhythmias, heart failure, unstable angina or revascularisation procedures) were included. MEDLINE, EMBASE, Cochrane Library, CINHAL, INAHTA and the Web of Science Core Collection were searched in April 2024.
Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases.
Appl Health Econ Health Policy
December 2024
Centre for Health Economics Research and Evaluation, University of Technology Sydney, Level 5, Building 20, 100 Broadway, Chippendale, Sydney, NSW, 2008, Australia.
Objective: This article reviews the assessment pathways that have been implemented worldwide to facilitate access to drugs for patients with rare diseases.
Methods: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were used to conduct a systematic literature review. The Ovid (Embase/MEDLINE), Cochrane, Web of Science, Econlit, National Institute of Health Research, Centre for Reviews and Dissemination, and International Network of Agencies for Health Technology Assessment databases were searched.
Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Nutr Rev
December 2024
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom.
Context: The use of prebiotics and probiotics as a treatment for psychiatric conditions has gained interest due to their potential to modulate the gut-brain axis. This review aims to assess the effectiveness of these interventions in reducing symptoms of depression and anxiety in psychiatric populations.
Objective: The aim was to comprehensively review and appraise the effectiveness of prebiotic, probiotic, and synbiotic interventions in reducing clinical depression and anxiety symptoms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!